Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".

Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2023
Historique:
received: 08 08 2022
accepted: 08 08 2022
medline: 18 4 2023
entrez: 17 4 2023
pubmed: 18 4 2023
Statut: epublish

Résumé

[This corrects the article DOI: 10.1155/2021/9996193.].

Identifiants

DOI: 10.1155/2023/9757348 PMID: 37065720 PMC: PMC10104731
pubmed: 37065720
doi: 10.1155/2023/9757348
pmc: PMC10104731
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

9757348

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2023 Brian Godman et al.

Références

Biomed Res Int. 2021 Oct 11;2021:9996193
pubmed: 34676266

Auteurs

Brian Godman (B)

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

Magdalene Wladysiuk (M)

Chair of Epidemiology and Preventive Medicine, Medical College, Jagiellonian University, Krakow, Poland.
HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland.

Stuart McTaggart (S)

Public Health Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, UK.

Amanj Kurdi (A)

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq.

Eleonora Allocati (E)

Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milan, Italy.

Mihajlo Jakovljevic (M)

Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
Institute of Comparative Economic Studies, Hosei University Tokyo, Japan.
Department of Global Health Economics and Policy, University of Kragujevac, Serbia.
ORCID: 0000-0002-9160-6846

Francis Kalemeera (F)

Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia.

Iris Hoxha (I)

Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania.

Anna Nachtnebel (A)

Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria.

Robert Sauermann (R)

Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria.

Manfred Hinteregger (M)

Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria.

Vanda Marković-Peković (V)

Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
ORCID: 0000-0001-8963-5720

Biljana Tubic (B)

Faculty of Medicine, Department of Medicinal Chemistry, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Agency for Medicinal Product and Medical Devices of Bosnia and Herzegovina, 78000 Banja Luka, Bosnia and Herzegovina.

Guenka Petrova (G)

Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria.
ORCID: 0000-0001-8116-5138

Konstantin Tachkov (K)

Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria.

Juraj Slabý (J)

State Institute for Drug Control, Prague, Czech Republic.

Radka Nejezchlebova (R)

State Institute for Drug Control, Prague, Czech Republic.

Iva Selke Krulichová (IS)

Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Simkova 870, 500 03 Hradec Králové, Czech Republic.

Ott Laius (O)

State Agency of Medicines, Nooruse 1, 50411 Tartu, Estonia.

Gisbert Selke (G)

Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany.

Irene Langner (I)

Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany.

András Harsanyi (A)

Department of Health Policy and Health Economics, Eotvos Lorand University, Budapest, Hungary.

András Inotai (A)

Syreon Research Institute and Semmelweis University, Center of Health Technology Assessment, Budapest, Hungary.
ORCID: 0000-0002-0663-2733

Arianit Jakupi (A)

Faculty of Pharmacy, UBT Higher Education Institute, Pristina, Kosovo.
ORCID: 0000-0002-7719-9690

Svens Henkuzens (S)

Independent Consultant, Riga, Latvia.

Kristina Garuolienė (K)

Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
ORCID: 0000-0001-7910-0108

Jolanta Gulbinovič (J)

Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
ORCID: 0000-0003-3776-6934

Patricia Vella Bonanno (PV)

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Department of Health Services Management, University of Malta, Valletta, Malta.

Jakub Rutkowski (J)

HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland.

Skule Ingeberg (S)

Medicines Committee, Oslo University Hospitals, Oslo, Norway.

Øyvind Melien (Ø)

Medicines Committee, Oslo University Hospitals, Oslo, Norway.

Ileana Mardare (I)

Faculty of Medicine, Public Health and Management Department, "Carol Davila" University of Medicine and Pharmacy Bucharest, 050463 Bucharest, Romania.

Jurij Fürst (J)

Health Insurance Institute, Miklosiceva 24, SI-1507 Ljubljana, Slovenia.

Sean MacBride-Stewart (S)

Pharmacy Services, Greater Glasgow and Clyde (NHS GGC), Glasgow, UK.

Carol Holmes (C)

NHS Lothian, Edinburgh, UK.

Caridad Pontes (C)

Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain.
Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.

Corinne Zara (C)

Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain.

Marta Turu Pedrola (MT)

Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain.

Mikael Hoffmann (M)

NEPI-Nätverk för Läkemedelsepidemiologi, Stockholm, Sweden.

Vasileios Kourafalos (V)

National Organization for the Provision of Healthcare Services (EOPYY), Athens, Greece.

Alice Pisana (A)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
ORCID: 0000-0001-8839-5171

Rita Banzi (R)

Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milan, Italy.
ORCID: 0000-0002-2211-3300

Stephen Campbell (S)

Centre for Primary Care and Health Services Research, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK.
NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester, UK.
ORCID: 0000-0002-2328-4136

Bjorn Wettermark (B)

Department of Pharmacy, Disciplinary Domain of Medicine and Pharmacy, Uppsala University, Uppsala, Sweden.

Classifications MeSH